Royalty Pharma, a business built on investing in other people’s medicines, raised $2.2 billion in a record IPO on Tuesday, and the early hours of trading boosted its valuation to more than $25 billion.
The company, founded in 1996, priced about 78 million shares at $28 each. Royalty Pharma opened trading at $44, an instant 57% increase, suggesting the company’s bankers left a fair amount of money on the table.
{iframe}https://www.statnews.com/2020/06/16/the-next-record-setting-ipo-a-drug-company-that-doesnt-develop-drugs/?utm_source=STAT+Newsletters&utm_campaign=332e845130-RO_COPY_04&utm_medium=email&utm_term=0_8cab1d7961-332e845130-149827193{/iframe}